New heart solution tested in Kids' surgery: could it offer better protection?
NCT ID NCT07381530
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two solutions, Custodiol and Custodiol-N, used to protect the heart during surgery for children with congenital heart defects. About 100 children will receive one of the two solutions while on a heart-lung machine. The goal is to see which one is safer and better at preventing heart damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Custodiol-N (a cardioplegia solution)
- What this could lead to
- If Custodiol-N proves safer or more protective, it could become a preferred option to protect children's hearts during surgery for birth defects.
- What could go wrong
- This is a small, early-phase trial that is currently suspended, so results may be delayed or never completed. The study compares two similar solutions, so a major breakthrough is unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Deutsches Herzzentrum München, TUM Universitätsklinikum, Klinik für Chirurgie angeborener Herzfehler und Kinderherzchirurgie
München, 80636, Germany
-
Universitätsklinikum Gießen und Marburg GmbH, Abteilung für Kinderherzchirurgie und angeborene Herzfehler
Giessen, 35385, Germany
-
Universitätsklinikum Münster, Klinik für Herz- und Thoraxchirurgie,Sektion Kinderherzchirurgie
Münster, 48149, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.